Literature DB >> 25160570

Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors.

T Y Zhu1, J F Griffith, L Qin, V W Y Hung, T-N Fong, S-K Au, A W Kwok, P-C Leung, E K Li, L-S Tam.   

Abstract

UNLABELLED: We investigated the densitometric and microstructural features of the distal radius in psoriatic arthritis (PsA) patients using high-resolution peripheral quantitative computed tomography. PsA patients have unique bone microstructural deficits, manifested as lower cortical bone density and higher cortical porosity, which are associated with a propensity to bone fragility.
INTRODUCTION: The aim of this study was to investigate the densitometric, geometric, microstructural, and biomechanical features of the distal radius in psoriatic arthritis (PsA) patients.
METHODS: This study cohort consisted of 53 PsA patients (24 males and 29 females), with an average age of 53.1 years and 53 gender- and age-matched controls. Areal bone mineral density (aBMD) of the hip, lumbar spine, and ultradistal radius was measured by dual-energy X-ray absorptiometry. High-resolution peripheral quantitative computed tomography (HR-pQCT) was performed at the distal radius to obtain measures of volumetric BMD (vBMD), microstructure, and derived biomechanical indices.
RESULTS: There were no significant between-group differences in aBMD at the femoral neck, total hip, and ultradistal radius, while aBMD at the lumbar spine was significantly higher in patients. The only indices indicating compromised bone quality in PsA patients were related to cortical bone quality. Cortical vBMD were -3.8% significantly lower, while cortical pore volume, porosity index, and pore diameter were 108, 79.5, and 8.6%, respectively, significantly higher in patients. Cortical stress was marginally lower (-1.3%, p = 0.077) in patients with stress significantly more unevenly distributed (4.9%, p = 0.035). Endocortical perimeter and cortical pore volume were significantly higher in patients with vertebral fracture. Deficits in cortical bone quality were associated with indices of disease activity/severity and were more prominent in patients with type 2 diabetes mellitus or hypertension.
CONCLUSIONS: There is an intertwined relationship between chronic inflammation, cardiovascular risk factors, and bone loss in PsA. PsA patients seem to have unique bone microstructural deficits which are associated with a propensity to bone fragility.

Entities:  

Mesh:

Year:  2014        PMID: 25160570     DOI: 10.1007/s00198-014-2858-3

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

1.  Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures.

Authors:  Manuel Riesco; Francisco Manzano; Pilar Font; Alicia García; Joan M Nolla
Journal:  Clin Rheumatol       Date:  2013-07-12       Impact factor: 2.980

2.  In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.

Authors:  Joshua N Farr; Matthew T Drake; Shreyasee Amin; L Joseph Melton; Louise K McCready; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

Review 3.  Type 2 diabetes and bone.

Authors:  William D Leslie; Mishaela R Rubin; Ann V Schwartz; John A Kanis
Journal:  J Bone Miner Res       Date:  2012-09-28       Impact factor: 6.741

4.  Bone mineral density in patients with psoriatic arthritis.

Authors:  B Frediani; A Allegri; P Falsetti; L Storri; S Bisogno; F Baldi; P Filipponi; R Marcolongo
Journal:  J Rheumatol       Date:  2001-01       Impact factor: 4.666

5.  Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry.

Authors:  Soumya M Reddy; Allen P Anandarajah; Mark C Fisher; Philip J Mease; Jeffrey D Greenberg; Joel M Kremer; George Reed; Rui Chen; Susan Messing; Kimberly Kaukeinen; Christopher T Ritchlin
Journal:  J Rheumatol       Date:  2010-09-15       Impact factor: 4.666

6.  Outcome measures in psoriatic arthritis.

Authors:  Dafna D Gladman; Philip J Mease; Paul Healy; Philip S Helliwell; Oliver Fitzgerald; Alberto Cauli; Ennio Lubrano; Gerald G Krueger; Désirée van der Heijde; Douglas J Veale; Arthur Kavanaugh; Peter Nash; Christopher Ritchlin; William Taylor; Vibeke Strand
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

7.  Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Mika Yamauchi; Hiroshi Kaji; Toshitsugu Sugimoto
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

8.  Cardiovascular morbidity in psoriatic arthritis.

Authors:  D D Gladman; M Ang; L Su; B D M Tom; C T Schentag; V T Farewell
Journal:  Ann Rheum Dis       Date:  2008-08-12       Impact factor: 19.103

9.  Time-lapsed assessment of microcrack initiation and propagation in murine cortical bone at submicrometer resolution.

Authors:  R Voide; P Schneider; M Stauber; P Wyss; M Stampanoni; U Sennhauser; G H van Lenthe; R Müller
Journal:  Bone       Date:  2009-05-03       Impact factor: 4.398

10.  Alterations of bone density, microstructure, and strength of the distal radius in male patients with rheumatoid arthritis: a case-control study with HR-pQCT.

Authors:  Tracy Y Zhu; James F Griffith; Ling Qin; Vivian W Hung; Tsz-Ning Fong; Sze-Ki Au; Martin Li; Yvonne Yi-On Lam; Chun-Kwok Wong; Anthony W Kwok; Ping-Chung Leung; Edmund K Li; Lai-Shan Tam
Journal:  J Bone Miner Res       Date:  2014-09       Impact factor: 6.741

View more
  6 in total

1.  Comparison of bone structure and microstructure in the metacarpal heads between patients with psoriatic arthritis and healthy controls: an HR-pQCT study.

Authors:  D Wu; J F Griffith; S H M Lam; P Wong; J Yue; L Shi; E K Li; I T Cheng; T K Li; V W Hung; L Qin; L-S Tam
Journal:  Osteoporos Int       Date:  2020-01-14       Impact factor: 4.507

2.  Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2.

Authors:  Jiayun Shen; Qing Shang; Chun-Kwok Wong; Edmund K Li; Emily W Kun; Isaac T Cheng; Martin Li; Tena K Li; Tracy Y Zhu; Cheuk-Man Yu; Ling Qin; Lai-Shan Tam
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

3.  Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.

Authors:  Agnete Malm Gulati; Mari Hoff; Øyvind Salvesen; Alvilde Dhainaut; Anne Grete Semb; Arthur Kavanaugh; Glenn Haugeberg
Journal:  RMD Open       Date:  2017-07-13

4.  Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients.

Authors:  David Simon; Arnd Kleyer; Sara Bayat; Koray Tascilar; Eleni Kampylafka; Timo Meinderink; Louis Schuster; Ramona Petrov; Anna-Maria Liphardt; Juergen Rech; Georg Schett; Axel J Hueber
Journal:  Arthritis Res Ther       Date:  2019-07-03       Impact factor: 5.156

5.  Progressive structural bone changes and their relationship with treatment in patients with psoriatic arthritis: a longitudinal HR-pQCT study.

Authors:  Dongze Wu; James F Griffith; Steven H M Lam; Priscilla C H Wong; Lin Shi; Edmund K Li; Isaac T Cheng; Tena K Li; Vivian W Hung; Ling Qin; Lai-Shan Tam
Journal:  Arthritis Res Ther       Date:  2019-12-04       Impact factor: 5.156

6.  Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population.

Authors:  Agnete Malm Gulati; Brigitte Michelsen; Andreas Diamantopoulos; Berit Grandaunet; Øyvind Salvesen; Arthur Kavanaugh; Mari Hoff; Glenn Haugeberg
Journal:  RMD Open       Date:  2018-06-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.